Teraplast (TRP) Q3 2026 earnings summary

Executive summary

• 9M 2026 revenue rose 10% YoY to RON 943.3m; EBITDA fell 15% to RON 61.2m and results swung to a RON 10.3m loss from RON 6.3m profit.

• International sales grew 16% to RON 345.7m, reaching 37% of revenue versus 35% in 9M 2025.

Financial highlights

• Gross margin increased to RON 356.8m, with the margin rising to 38% from 37%; EBITDA margin fell to 6.5% from 8.4%.

• Sales volume declined 3% to 95,799 tonnes; higher raw-material, transportation and energy costs pressured profitability.

• EBIT was RON 16.7m versus RON 29.4m; net financial costs increased to RON 23.4m from RON 18.8m.

• Operating cash flow was negative RON 21.8m, improving from negative RON 41.9m.

Outlook and guidance

• FY 2026 revenue is forecast at RON 1.24bn, up 14% YoY; EBITDA at RON 70m and net loss at RON 25m.

• Q4 seasonal demand moderation and price pressure are expected to weigh on construction- and infrastructure-linked activities; Q4 is not expected to offset YTD profitability deterioration.

• No significant year-end demand recovery is expected for Compounds and Windows; Packaging performance depends on raw-material prices and order trends.

• Guidance excludes purchase price allocation adjustments for the Spanish plant; fair-value impacts are expected to be recorded in Q4.